SCHEMBL29822136

SCHEMBL29822136

Nc1cc(Cl)c(Oc2ccc(=O)n(Cc3cccc(C(F)(F)F)c3)c2)c(Cl)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPBWR1 P48145 1/20 0.50
▸ MKNK1 Q9BUB5 2/20 0.48
▸ MKNK2 Q9HBH9 2/20 0.48
▸ LMNA P02545 2/20 0.46
▸ L3MBTL1 Q9Y468 1/20 0.45
▸ MAPT P10636 5/20 0.44
▸ GAA P10253 1/20 0.44
▸ SMN1; SMN2 Q16637 1/20 0.44
▸ MAPK1 P28482 1/20 0.44
▸ MAOB P27338 2/20 0.43
▸ TP53 P04637 1/20 0.41
▸ RXFP1 Q9HBX9 1/20 0.41
▸ PDGFRA P16234 2/20 0.41
▸ S1PR1 P21453 2/20 0.41
▸ S1PR5 Q9H228 2/20 0.41
▸ PIM1 P11309 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ THRA P10827 1/20 0.41
▸ THRB P10828 1/20 0.41
▸ P2RX7 Q99572 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24819269 1.00 NPBWR1 (0.50) NPBWR1MKNK1MKNK2LMNAL3MBTL1
SCHEMBL24820993 0.85 MKNK1 (0.42) NPBWR1MKNK1MKNK2MAPTTHRA
SCHEMBL29821988 0.85 NPBWR1 (0.48) NPBWR1MKNK1MKNK2LMNAL3MBTL1
SCHEMBL24819271 0.85 NPBWR1 (0.48) NPBWR1MKNK1MKNK2LMNAL3MBTL1
SCHEMBL23168654 0.83 MAPT (0.51) NPBWR1LMNAL3MBTL1MAPTSMN1; SMN2
SCHEMBL29821419 0.83 MAPT (0.51) NPBWR1LMNAL3MBTL1MAPTSMN1; SMN2
SCHEMBL23168745 0.83 KLKB1 (0.40) NPBWR1THRATHRB
SCHEMBL23168751 0.82 NPBWR1 (0.37) NPBWR1LMNAMAPTTP53P2RX7
SCHEMBL23168940 0.81 MAPT (0.40) LMNAMAPTSMN1; SMN2MAOBTP53
SCHEMBL23168951 0.81 MAPT (0.40) MAPTGAAP2RX7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617769-B2 Chemical compound as thyroid hormone beta receptor agonist and use thereof SUNSHINE LAKE PHARMA CO., LTD. (CN) 2026-05-05 — — US disclosed
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2022-12-29 — — US disclosed
EP-4036090-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF Sunshine Lake Pharma Co., Ltd. (CN) 2022-08-03 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220411400-A1 CHEMICAL COMPOUND AS THYROID HORMONE BETA RECEPTOR AGONIST AND USE THEREOF THRB, TSHR, THRA NPBWR1 336/4885MKNK1 1754/4885MKNK2 1954/4885
US-12617769-B2 Chemical compound as thyroid hormone beta receptor agonist and use thereof THRB, TSHR, THRA NPBWR1 267/4885MKNK1 3781/4885MKNK2 4060/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback